AI Market Mood: Stock Dashboard
TFX
Fundamental
Company: Teleflex Incorporated
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: USA
Exchange: NYSE
Index: -
P/E: -
EPS (ttm): -20.56
Insider Own: 0.45%
Shs Outstand: 44.20M
Perf Week: 0.64%
Market Cap: 5.11B
Forward P/E: 11.41
EPS next Y: 10.14
Insider Trans: 0.00%
Shs Float: 44.00M
Perf Month: 2.08%
Enterprise Value: 7.45B
PEG: 0.62
EPS next Q: 1.21
Inst Own: 107.38%
Short Float: 5.21%
Perf Quarter: -7.06%
Income: -905.64M
P/S: 1.73
EPS this Y: -4.46%
Inst Trans: 1.16%
Short Ratio: 2.34
Perf Half Y: -11.63%
Sales: 2.96B
P/B: 1.64
EPS next Y Percentage: 52.02%
ROA: -2.77%
Short Interest: 2.29M
Perf YTD: -5.22%
Book/sh: 70.70
P/C: 13.00
EPS next 5Y: 18.38%
ROE: -5.26%
52W High: 138.93 -16.74%
Perf Year: -11.49%
Cash/sh: 8.90
P/FCF: 20.83
EPS past 3/5Y: - -
ROIC: -15.75%
52W Low: 100.18 15.46%
Perf 3Y: -55.93%
Dividend Est.: 1.36 (1.17%)
EV/EBITDA: 11.66
Sales past 3/5Y: -10.62% -4.72%
Gross Margin: 60.55%
Volatility W: 3.02%
Volatility M: 3.06%
Perf 5Y: -72.43%
Dividend TTM: 1.36 (1.18%)
EV/Sales: 2.51
EPS Y/Y TTM: -1515.83%
Oper. Margin: 15.55%
ATR (14): 3.82
Perf 10Y: -26.54%
Dividend Ex-Date: Mar 06, 2026
Quick Ratio: 2.01
Sales Y/Y TTM: -2.75%
Profit Margin: -30.56%
RSI (14): 55.82
Recom: 2.77
Dividend Gr. 3/5Y: 0.00% 0.00%
Current Ratio: 2.54
EPS Q/Q: -447.95%
SMA20: 3.91%
Beta: 0.84
Target Price: 130.22
Payout: -
Debt/Eq: 0.87
Sales Q/Q: -28.47%
SMA50: 4.47%
Rel Volume: 0.28
Prev Close: 115.04
Employees: 15500
LT Debt/Eq: 0.84
Earnings: Feb 26 BMO
SMA200: -1.72%
Avg Volume: 978.69K
Price: 115.67
IPO: Apr 24, 1967
Option/Short: Yes / Yes
EPS/Sales Surpr.: -48.67% -38.11%
Trades:
Volume: 205,873
Change: 0.55%
Technical:
Latest News:
Wells Fargo Sticks to Its Hold Rating for Teleflex (TFX) | Markets Insider neutral
TFX TFX
Summary: Analysts from Wells Fargo, Needham, and JMP Securities recently provided ratings on Teleflex (TFX) with varying perspectives. Teleflex reported a quarterly revenue of $773.91 million, slightly higher than the previous year, but with a lower net profit. The company provides medical technology products focused on improving patient outcomes and safety.
Full article2024-05-03T18:12:46Z